Neuro
Botulism
search
Botulism
, Clostridium botulinum, C. botulinum, Botulinum Toxin, Wound Botulism
See Also
Infant Botulism
Biological Neurotoxin
Bioterrorism
Floppy Infant
Etiology
Clostridium botulinum
Gram Positive
rod
Anaerobic
Spore forming
Bacteria
Pathophysiology
Toxin mediated disease
Botulinum Toxin is heat labile (inactivated at high
Temperature
)
Botulinum Toxin has 7 different serotypes
Botulinum Toxins A, B and E are pathogenic in humans
Botulinum Toxin is typically cleaved into active heavy chains and light chains
Heavy chains irreversibly bind
Acetylcholine
containing
Neuron
s
Light chains interfere with
Acetylcholine
exocytosis
Botulinum Toxin binds to presynaptic nerve terminal
Neuromuscular terminal
Cholinergic
autonomic site
Receptor binding is irreversible
Receptors are replaced however over time
Affects
Neuromuscular Junction
only
Prevents presynaptic
Acetylcholine
release
Results in bulbar palsy (
CN 9
-12),
Autonomic Dysfunction
and skeletal
Muscle Weakness
Does not cause sensory deficit or pain
Botulinum Toxin medical uses (
Botox
)
Treatment for oculomotor disorders
Strabismus
Blepharospasm
Treatment for
Dystonia
s
Torticollis
Hemifacial spasm
Transmission
Not spread from person to person
Aerosol spread as warfare
Biological Toxin
Incubation: 1 to 5 days
Wound Infection
Associated with
Trauma
and
IV Drug Abuse
(e.g.
Heroin
use)
Course differs from
Foodborne Illness
Longer
Incubation Period
: 4 to 14 days
Minimal gastrointestinal symptoms
Foodborne Illness
(ingestion of
Bacteria
or preformed toxin)
Incubation: 12-72 hours (median 24 hours)
Toxin types A and B in the United States
West of the Mississippi: Type A toxins
East of the Mississippi: Type B toxins
Ingested spores (esp. from honey) may also cause Botulism in high risk patients
Spores germinate in
Stomach
, grow and produce toxin (incubates over weeks)
Infants (See
Infant Botulism
)
Altered
Gastrointestinal Tract
(e.g.
Gastric Bypass
surgery,
Proton Pump Inhibitor
s)
Improperly preserved pickled or canned foods (e.g. tomatoes)
In-ground vegetables (potatoes, onions,
Garlic
)
Potatoes baked in aluminum foil
Meat products in Europe (Toxin Type B)
Vegetable products in China (Toxin Type A)
Preserved fish (Toxin type E)
Found in Alaska, Japan, Russia, Scandinavia
Symptoms
Sudden onset symptoms
Symptoms follow ingestion or exposure by 12-72 hours, or inhalation by 12-80 hours
No associated fever
Descending symmetric paralysis
Early changes:
Cranial Nerve
palsy occurs first
Diplopia
with
Blurred Vision
(90%)
Dysphagia
(76%)
Dysarthria
Dysphonia
(55%)
Later changes
Progressive, bilateral descending
Flaccid Paralysis
Gene
ralized Weakness (58%)
Anticholinergic Symptoms
Dry Mouth
Decreased tears
Blurred Vision
Dizziness
Urinary Retention
Abdominal Pain
or cramping (ileus)
Constipation
Other symptoms
Nausea
or
Vomiting
(56%)
Headache
Fever
(Wound Botulism)
Signs
Early signs
Bilateral
Cranial Nerve 6
(
Abducens Nerve
) paralysis
Ptosis
Mydriasis
with sluggish pupil reaction
Nystagmus
Diminished
Gag Reflex
Swollen
Tongue
Later signs
Symmetrical descending
Flaccid Paralysis
Hyporeflexia
Incoordination
Irregular respirations to
Respiratory Failure
Distinguishing features from other causes
Mentation clear
Patient is usually afebrile
Neurologic changes are bilateral, descending and motor (not sensory)
Differential Diagnosis
See
Floppy Infant
Myasthenia Gravis
Guillain Barre Syndrome
Eaton-Lambert Syndrome
Trichinosis
Cerebrovascular Accident
Electrolyte
disturbance
Hypocalcemia
Hypermagnesemia
Tick Paralysis
or
Tick Toxicosis
(ascending paralysis)
Other toxin exposure
Organophosphate Poisoning
Atropine
Poisoning
Shellfish
Poisoning
or puffer fish
Poisoning
Labs
Precautions
Labs are sent, but typically delayed, and diagnosis and management is started empirically
Patient sources
Serum for Botulinum Toxin (positive in 1/3 of cases)
Gastric contents for Botulinum Toxin
Stool
for Botulinum Toxin (positive in 1/3 of cases)
Stool
for culture (positive in 60% of cases)
Wound
culture (if present) for organisms
Test suspected food source for toxin
Classic testing (historical)
Lab mice die after ingesting suspected food source
Illness reversed by type specific antitoxin
Other testing to consider
Lumbar Puncture
(evaluate differential diagnosis)
Diagnostics
Negative
Inspiratory Force
Electromyogram
(EMG)
Protocol
Initial supramaximal single nerve stimulation
Repetitive stimulation at 40 to 50 hz
Differentiates from other neuromuscular conditions
Single maximal stimulus: Diminished
Action Potential
s
Repetitive stimuli: Facilitation of
Action Potential
s
Hypermagnesemia
may give similar EMG
Other testing
Edrophonium Test
ing
Management
Gene
ral
Contact Centers for Disease Control for suspected cases
Supportive care
Ventilator
support often required
Follow
Vital Capacity
on serial
Pulmonary Function Test
ing
Gastric Decontamination
if recent ingestion in foodborne Botulism
Consider even in delayed presentation
If no ileus, may give
Laxative
s and enemas
Surgical
Wound Debridement
in Wound Botulism
Indicated even in benign appearing wounds
Antibiotic
precautions
Antibiotic
s are only recommended in Wound Botulism
First-Line
Penicillin G
3 million units IV q4 hours
Alternative (if
Penicillin
allergic)
Metronidazole
(
Flagyl
) 500 mg IV every 8 hours
Avoid
Aminoglycoside
s and
Clindamycin
Antitoxin
Indicated in both food-borne and Wound Botulism in adults and children over age 1 year
See below
Other measures
Tetanus Toxoid
booster
Management
Antitoxin (from CDC)
May shorten disease course if used early
Does not reverse paralysis, but stops progression
Indicated in both food-borne and Wound Botulism in adults and children over age 1 year
Depreciated Heptavalent equine antitoxin (preferred)
Available from CDC and from state department
Covers types A, B, C, D, E, F, G
Reduced risk of
Serum Sickness
Effective if given prior to or early in symptoms
Trivalent equine antitoxin (replaced by heptavalent
Vaccine
)
Risk of
Serum Sickness
and
Anaphylaxis
Skin Test for Horse Serum Sensitivity
first
Do not use in
Infant Botulism
Prevention
Avoid honey in infants under 1 year of age
See
Infant Botulism
DOD Pentavalent toxoid
Vaccine
Covers types A, B, C, D, E
Dose: 0.5 SC at 0, 2, and 12 weeks, then annually
Protective
Antibody
>90% after 1 year
Prognosis
Untreated: Mortality 60% from
Respiratory Failure
Treated with intensive support: Mortality <7%
Resources
CDC Disease Information
http://emergency.cdc.gov/bioterrorism/index.asp
References
(2019) Sanford Guide, acccessed 6/5/2019
Bartlett in Goldman (2000) Cecil Medicine, p. 1673-4
Schechter in Behrman (2000) Nelson Pediatrics, p. 875-8
Seeyave (2015) Crit Dec Emerg Med 29(5): 13-21
Shearer in Marx (2002) Rosen's Emergency Med, p. 1525
Sun and Tomaszewski (2017) Crit Dec Emerg Med 31(6): 24
Arnon (2001) JAMA 285:1059-70 [PubMed]
Rathjen (2021) Am Fam Physician 104(4): 376-85 [PubMed]
Type your search phrase here